21.400
−6,96%
2026-10-15
Fundamental Analysis
93 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +156.1% | +74.2% | 3 / 3 | +22.7% | -0.76 pp | +2.28 pp | +28.0% | 0.00 | 4.98 | 595 | +22,7% | 26,1 | +156,1% | 4.98 | 6.69 | −25,6% |
| Pts | 12 | 12 | 12 | 12 | 4 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 21.400 (close price on 2026-10-15)EPS (TTM): 4.300
Financial charts
1.Revenue & growth
VND bn595Q2/26
1.Revenue & growth
VND bn595Q2/26
2.Profit & growth
VND bn26,1Q2/26
3.Profit mix (Penman)
VND bn115Q2/26
4.Margins & cost structure
%15.1%Q2/26
5.Returns & cash cycle
% · days69.9%Q2/26
6.Earnings quality & cash
VND bn63,6Q2/26
7.Asset structure
VND bn862Q2/26
8.Funding & debt health
VND bn · times862Q2/26
9.Revenue backlog
VND bn1,77Q2/26
10.Valuation
times · %5,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.242Q2/26
Adjusted EPS growth, latest quarter
156%
Average adjusted EPS growth, 3 quarters
74.2%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26